John Overdeck’s ResMed RMD Stock Holding History

John Overdeck’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-7,500	Closed	-$1.95M	–	4056
2021 Q4	$1.95M	Buy	7,500 +6,700	+838%	+$1.74M	﹤0.01%	1936
2021 Q3	$211K	Buy	+800	New	+$219K	﹤0.01%	3932
2021 Q1	–	Sell	-2,300	Closed	-$489K	–	4192
2020 Q4	$489K	Buy	+2,300	New	+$459K	﹤0.01%	2535
2020 Q3	–	Sell	-2,000	Closed	-$384K	–	3487
2020 Q2	$384K	Sell	2,000 -4,300	-68%	-$704K	﹤0.01%	2201
2020 Q1	$928K	Buy	6,300 +4,300	+215%	+$685K	0.01%	1462
2019 Q4	$310K	Sell	2,000 -900	-31%	-$130K	﹤0.01%	3164
2019 Q3	$392K	Buy	+2,900	New	+$380K	﹤0.01%	2747

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

John Overdeck's RMD Position: Q2 2026 in Review

John Overdeck increased its ResMed (RMD) stake by 32% in Q2 2026, buying an estimated $20.4M and bringing the position to 411,036 shares worth $80.1M. The position accounts for 0.06% of the portfolio, ranked #384.

John Overdeck first reported a position in RMD in Q2 2013 and has held it in 23 quarters since. The position peaked at $138M in Q3 2023. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

John Overdeck held 411,036 shares of ResMed worth $80.1M as of Q2 2026.
John Overdeck bought 98,568 ResMed shares in Q2 2026, an estimated $20.4M.
ResMed made up 0.06% of John Overdeck's portfolio in Q2 2026, its #384 holding.
John Overdeck first reported a position in ResMed in Q2 2013 and has held it in 23 quarters since.
John Overdeck's ResMed position peaked at $138M in Q3 2023.
880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.